Core Insights - Tenet Healthcare reported revenue of $5.12 billion for the quarter ended September 2024, reflecting a year-over-year increase of 1.1% and surpassing the Zacks Consensus Estimate of $5.05 billion by 1.48% [1] - The company's EPS for the quarter was $2.93, significantly higher than the $1.44 reported in the same quarter last year, and exceeded the consensus estimate of $2.33 by 25.75% [1] Financial Performance Metrics - Net Operating Revenues were $5.12 billion, compared to the three-analyst average estimate of $5.05 billion, marking a year-over-year change of +1.1% [3] - Net Operating Revenues from Ambulatory Care reached $1.14 billion, exceeding the average estimate of $1.07 billion, with a year-over-year increase of +21% [3] - Net Operating Revenues from Hospital Operations and other segments totaled $3.98 billion, slightly above the average estimate of $3.96 billion, reflecting a year-over-year change of +1.6% [3] - Adjusted EBITDA for Hospital Operations and other was reported at $539 million, surpassing the average estimate of $473.79 million [3] - Equity in earnings of unconsolidated affiliates was $62 million, compared to the average estimate of $64.09 million [3] - Adjusted EBITDA for Ambulatory Care was $439 million, slightly above the average estimate of $432.72 million [3] Stock Performance - Tenet's shares have declined by 16.1% over the past month, while the Zacks S&P 500 composite has increased by 1.7% [4] - The stock currently holds a Zacks Rank 2 (Buy), indicating potential for outperformance in the near term [4]

Tenet Healthcare (THC) came out with quarterly earnings of $2.93 per share, beating the Zacks Consensus Estimate of $2.33 per share. This compares to earnings of $1.44 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 25.75%. A quarter ago, it was expected that this hospital operator would post earnings of $1.89 per share when it actually produced earnings of $2.31, delivering a surprise of 22.22%.Over the last four quarters, th ...

Wall Street analysts forecast that Tenet Healthcare (THC) will report quarterly earnings of $2.33 per share in its upcoming release, pointing to a year-over-year increase of 61.8%. It is anticipated that revenues will amount to $5.05 billion, exhibiting a decline of 0.4% compared to the year-ago quarter. Over the last 30 days, there has been an upward revision of 0.2% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration ...

Hospital company Tenet Healthcare Corporation (THC) is set to report its third-quarter 2024 results on Oct. 29, 2024, before the opening bell. The Zacks Consensus Estimate for the to-be-reported quarter’s earnings and revenues is pegged at $2.33 per share and $5.05 billion, respectively.Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.The earnings estimate for the to-be-reported quarter has remained stable over the past 60 days. The bottom-line projection indicates year-over-year gro ...

Hospital company Tenet Healthcare Corporation (THC) is trading comparatively cheap at the moment from a valuation standpoint. Its forward earnings multiple of 14.75 is lower than the industry average of 16.18. The stock also looks attractively valued relative to other medical facility operators like HCA Healthcare, Inc. (HCA) and Encompass Health Corporation (EHC) , with forward 12-month P/E of 16.62X and 21.33X. Tenet Healthcare has a Value Score of A. Zacks Investment Research Image Source: Zacks Investme ...

Tenet Healthcare (THC) closed the most recent trading day at $152.78, moving -0.84% from the previous trading session. The stock's performance was behind the S&P 500's daily loss of 0.21%. Elsewhere, the Dow saw a downswing of 0.14%, while the tech-heavy Nasdaq depreciated by 0.05%. Prior to today's trading, shares of the hospital operator had lost 2.28% over the past month. This has was narrower than the Medical sector's loss of 3.28% and lagged the S&P 500's gain of 5.94% in that time. The investment comm ...

Group 1 - Tenet Healthcare's stock closed at $156.57, reflecting a slight decrease of -0.11% from the previous session, underperforming compared to the S&P 500's gain of 0.9% [1] - Over the past month, Tenet Healthcare's stock has declined by 3.24%, contributing to a loss of 4.05% in the Medical sector, while the S&P 500 gained 3.15% [1] Group 2 - The upcoming earnings report for Tenet Healthcare is scheduled for October 29, 2024, with an expected EPS of $2.33, representing a significant increase of 61.81% year-over-year [2] - Revenue is anticipated to be $5.05 billion, indicating a slight decrease of 0.41% compared to the same quarter last year [2] Group 3 - For the full year, Zacks Consensus Estimates project earnings of $10.72 per share and revenue of $20.84 billion, reflecting increases of 53.58% and 1.4% respectively compared to the previous year [3] Group 4 - Recent adjustments to analyst estimates for Tenet Healthcare suggest positive sentiment regarding the company's business operations and profit generation capabilities [4] - The Zacks Rank system, which evaluates these estimate changes, currently ranks Tenet Healthcare as 1 (Strong Buy), indicating strong potential for stock performance [6] Group 5 - Tenet Healthcare's Forward P/E ratio is 14.62, which is lower than the industry average of 15.39, suggesting that the stock may be undervalued [7] - The company's PEG ratio stands at 0.8, compared to the industry average of 1.13, indicating favorable growth expectations relative to its valuation [8] Group 6 - The Medical - Hospital industry, which includes Tenet Healthcare, holds a Zacks Industry Rank of 2, placing it in the top 1% of over 250 industries, suggesting strong overall performance potential [8][9]

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price. Do they really matter, though? Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let's see what these Wall Street heavyweights think about Tenet Healthcare (THC) . Tenet currently has an average brokerag ...

Momentum investing is essentially an exception to the idea of "buying low and selling high." Investors following this style of investing are usually not interested in betting on cheap stocks and waiting long for them to recover. Instead, they believe that "buying high and selling higher" is the way to make far more money in lesser time. Everyone likes betting on fast-moving trending stocks, but it isn't easy to determine the right entry point. These stocks often lose momentum when their future growth potent ...

Tenet Healthcare (THC) closed at $166.20 in the latest trading session, marking a +1.83% move from the prior day. The stock outpaced the S&P 500's daily gain of 0.42%. Meanwhile, the Dow gained 0.04%, and the Nasdaq, a tech-heavy index, added 0.38%. Prior to today's trading, shares of the hospital operator had lost 1.58% over the past month. This has was narrower than the Medical sector's loss of 2.49% and lagged the S&P 500's gain of 2.06% in that time. The investment community will be closely monitoring t ...